Athena Countouriotis - Net Worth and Insider Trading

Over the past 18 months, Athena Countouriotis made no insider transaction in Iovance Biotherapeutics Inc (IOVA). Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 290,000 shares made by Merrill A Mcpeak , a net purchase of 20,000,000 shares made by Wayne P. Rothbaum , and a net purchase of 10,000 shares made by Iain D. Dukes .

In summary, during the past 3 months, insiders sold 0 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 5,250,000 shares, with a net purchase of 5,250,000 shares. During the past 18 months, 0 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 20,301,000 shares were bought by its insiders, resulting in a net purchase of 20,301,000 shares.

Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Athena Countouriotis made no insider transaction in Passage Bio Inc (PASG). Other recent insider transactions involving Passage Bio Inc (PASG) include a net sale of 13,506 shares made by Simona King , a net sale of 7,772 shares made by Alexandros Fotopoulos , and a net purchase of 1,192,577 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 3,108 shares of Passage Bio Inc (PASG) in total and bought 0 shares, with a net sale of 3,108 shares. During the past 18 months, 29,386 shares of Passage Bio Inc (PASG) were sold and 1,192,577 shares were bought by its insiders, resulting in a net purchase of 1,163,191 shares.

Passage Bio Inc (PASG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Athena Countouriotis made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace , and a net purchase of 10,000 shares made by Mark Erlander .

In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 62,950 shares were bought by its insiders, resulting in a net purchase of 62,950 shares.

Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Athena Countouriotis made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Athena Countouriotis made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 235,862 shares made by Michael J. Labarre , a net sale of 251,061 shares made by Helen Torley , and a net sale of 7,525 shares made by Nicole Labrosse .

In summary, during the past 3 months, insiders sold 60,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 564,448 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 564,448 shares.

Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.